Published Clinical Study Illustrates Benefits of Promentum® Recover as Low-Dose Solution for Post Exercise Recovery

FutureCeuticals, Inc.

 

MOMENCE, Ill., April 23, 2026 /PRNewswire/ -- A recently published human clinical study demonstrates that Promentum® Recover, a patent-pending formula from FutureCeuticals anchored by calcium fructoborate in combination with low doses of turmeric and pomegranate extracts, delivers statistically significant post‑exercise recovery benefits. Promentum® Recover was shown to deliver a unique suite of benefits following strenuous exercise, including reduced muscle soreness, enhanced feelings of recovery, improved mental energy, and improved sleep quality.

 

The randomized, double‑blind, placebo‑controlled study, conducted at Loughborough University, evaluated Promentum Recover in recreationally active adults following a strenuous bout of muscle‑damaging exercise.

 

Participants using Promentum Recover experienced significant reductions in post‑exercise muscle soreness as indicated by a reduction in muscle pain of over 17% compared to placebo 72 hours following muscle-damaging exercise.

 

Additionally, Promentum Recover significantly improved other, non-physical aspects of how participants felt during their recovery period. Responding to questions directly assessing exercise-induced exhaustion, individuals reported feeling more recovered throughout 72-hours post‑exercise, indicating a faster return to readiness after training.

 

The benefits extended to significant improvements in feelings of mental energy and sleep quality. Participants reported feeling less mentally drained and experienced better sleep quality following the strenuous exercise. The researchers noted the connection between strenuous workouts and subsequent sleep disruption, which further complicates and delays recovery.

 

The study authors noted that the small, 300 mg dose included "markedly lower" doses of turmeric and pomegranate extracts than typically used to achieve recovery benefits, and that the potential synergies of these extracts with calcium fructoborate were worthy of further investigation and could not be ruled out.

 

"This study marks the first published clinical investigation of our marquis ingredient, calcium fructoborate, in an exercise‑recovery context, expanding our wide body of existing research on the patented mineral complex into the sports nutrition market with newly added benefits," said J. Randal Wexler, Vice President of R&D and General Counsel at FutureCeuticals.  "These recovery benefits are a natural complement to our long history of clinical and commercial success in the joint and mobility space."

 

About FutureCeuticals, Inc.
FutureCeuticals, Inc. is the exclusive developer of Promentum® Recover and a leader in the research, development and manufacture of plant-based powders and extracts for the functional food, beverage, and dietary supplement markets.

 

PR Newswire Asia Ltd.

 

 

PR Newswire
1954年に設立された世界初の米国広報通信社です。配信ネットワークで全世界をカバーしています。Cision Ltd.の子会社として、Cisionクラウドベースコミュニケーション製品、世界最大のマルチチャネル、多文化コンテンツ普及ネットワークと包括的なワークフローツールおよびプラットフォームを組み合わせることで、様々な組織のストーリーを支えています。www.prnasia.com

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

プレスリリース添付画像

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中